What is Umckaloabo?

Umckaloabo is a root extract from Pelargonium sidoides, a flowering plant native to South Africa. Its name comes from the Zulu words roughly translating to 'heavy cough,' reflecting its long history as a traditional remedy for chest and respiratory complaints. The extract — most famously standardized as EPs 7630 — has become a widely used herbal preparation for acute respiratory infections in European phytomedicine, though the overall body of evidence supporting it remains an active area of investigation.

How does Umckaloabo work?

Umckaloabo is thought to work through several pathways: it may inhibit the attachment of bacteria and viruses to the lining of the respiratory tract, potentially making it harder for pathogens to take hold. It is also believed to interact with the immune system by influencing natural killer cell activity and the release of interferon, the body's own antiviral signaling protein. Additionally, it may help thin and move mucus out of the airways, which could make breathing easier during respiratory illness.

What forms does Umckaloabo come in?

The liquid drop form (EPs 7630) is the most widely used, especially in children due to easy dose adjustment. Tablets and syrups are common in European markets. Capsules are available in North American health stores. Look for products standardized to EPs 7630 or specifying a defined Pelargonium sidoides root extract to ensure you are getting a well-standardized product.

Where it comes from:

Zulu and Basotho healers in southern Africa used the root of Pelargonium sidoides for generations to treat what they called 'heavy cough' — a term that likely included tuberculosis and serious chest infections. A British prospector named Charles Stevens reportedly brought the remedy to England in the early 1900s after using it to treat his own tuberculosis, sparking European interest. Modern pharmacological investigation began in the 1970s, and the standardized extract EPs 7630 was developed and used primarily in Germany from the 1990s onward, leading to its approval as a licensed herbal medicine in several European countries.

What does Umckaloabo help with?

• Acute bronchitis: Umckaloabo has been traditionally used for bronchitis and is among its most common applications in herbal practice. It is thought to work by potentially interfering with bacterial adhesion to the airway lining and by helping to thin mucus so the body can clear it more easily. Any reduction in symptom duration or severity remains plausible based on traditional use and early research, but should not be taken as established clinical fact.
• Common cold: In traditional practice, Umckaloabo has been used at the first sign of a cold with the aim of shortening symptom duration and reducing severity. It is thought to support the immune system's early response by influencing interferon levels and natural killer cell activity, though the extent of any real-world benefit has not been definitively confirmed in rigorous clinical trials.
• Acute sinusitis: Practitioners have traditionally used Umckaloabo to help ease sinus pressure, nasal congestion, and headache associated with acute sinusitis. It is thought to work by potentially addressing the infectious cause and supporting sinus drainage. Claims that it meaningfully reduces antibiotic use in mild-to-moderate cases remain observational and have not been firmly established.
• Sore throat and tonsillitis: Umckaloabo has traditionally been used to help relieve throat pain, difficulty swallowing, and redness associated with acute tonsillitis or pharyngitis in both adults and children. It is thought that it may make it harder for bacteria to adhere to throat tissue, though this mechanism and any clinical benefit remain preliminary and not conclusively proven.
• Ear infections in children: Umckaloabo has been used in some European countries as a traditional herbal option for acute otitis media in children, particularly when given early in the course of illness. Observations from traditional practice suggest possible benefit in reducing duration and severity, but robust clinical evidence confirming these effects in children is limited.
• Recurring respiratory infections: For people who experience frequent respiratory infections — especially children in daycare or school settings — Umckaloabo has traditionally been used with the aim of reducing infection frequency or severity, possibly through mild ongoing immune support. This application is based largely on traditional use and observational reports rather than confirmed clinical evidence.
• Flu-like symptoms: While not a specific antiviral for influenza, Umckaloabo has traditionally been used during flu-like illness to help ease symptoms such as cough, fatigue, and body aches. Any potential shortening of the symptomatic period is thought to relate to its possible broad antiviral and immune-supporting properties, though this has not been conclusively demonstrated in clinical settings.
• COPD flare-ups: Preliminary and observational reports have raised the possibility that Umckaloabo may help reduce the frequency or severity of acute respiratory flare-ups in people with COPD, potentially by influencing bacterial load in the airways and supporting mucus clearance. This remains an early and unconfirmed area of interest, and it should not be considered an established treatment for COPD.

What can Umckaloabo help prevent?

• May reduce the frequency of recurrent acute respiratory infections in children when used during infection-prone seasons
• May reduce the likelihood of antibiotic use in mild-to-moderate acute bronchitis and sinusitis by resolving infection naturally

Which foods are rich in Umckaloabo?

Umckaloabo is an isolated plant root extract with no meaningful dietary food source — you cannot get it from eating any common food. However, you can support your respiratory immune defenses with a diet rich in: dark berries and red grapes (which contain similar proanthocyanidins and polyphenols), garlic and onions (natural antimicrobial and immune-boosting sulfur compounds), citrus fruits and bell peppers (high vitamin C to shorten cold duration), ginger and turmeric (anti-inflammatory support for the respiratory tract), and warming broths and soups that help thin mucus and keep airways moist. Avoid excess sugar and alcohol during active respiratory infection, as both suppress immune response.

What are the side effects of Umckaloabo?

• Mild stomach upset or nausea (most common)
• Loose stools or mild diarrhea
• Skin rash or mild allergic reaction (rare)
• Bleeding tendency at high doses (rare, due to coumarin content)
• Liver enzyme elevation (rare, reported in post-market surveillance)
• Headache (uncommon)

Good to know:

Umckaloabo is considered safe and well tolerated in both adults and children at recommended doses. Most side effects are mild and gastrointestinal. Rare cases of liver inflammation have been reported in post-market surveillance, so it should be used with caution in those with liver conditions. It is not recommended during pregnancy or breastfeeding due to insufficient safety data.

How much Umckaloabo should you take?

• Recommended daily: Adults: 30 drops (1.5 mL) of EPs 7630 liquid extract three times daily, OR 20 mg tablet three times daily. Children 6–12: 20 drops three times daily. Children 1–5: 10 drops three times daily. (All doses of the standardized EPs 7630 extract.)
• Best time of day: Spread doses evenly through the day — morning, midday, and evening — to maintain consistent levels in the body during acute infection.
• With or without food: Can be taken with or without food. Some people prefer taking it with a small amount of food or water to reduce the chance of stomach upset.
• Time to effect: Most people notice meaningful symptom improvement within 3–5 days of consistent use. Full benefit is typically seen by day 7.
• How long to take it: Use only during acute illness — typically 7 to 10 days maximum per episode. Not intended for long-term daily use or as a year-round supplement. Allow at least 2 weeks off between courses.